1. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells
    Cong Wang et al, 2017 CrossRef
  2. Design, synthesis and evaluation of the multidrug resistance-reversing activity of pyridine acid esters of podophyllotoxin in human leukemia cells
    Lei Zhang et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
  3. Novel isatin derivatives of podophyllotoxin: synthesis and cytotoxic evaluation against human leukaemia cancer cells as potent anti-MDR agents
    Lei Zhang et al, 2015, RSC Adv. CrossRef
  4. Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs
    Xu Zhang et al, 2017, Bioorganic & Medicinal Chemistry CrossRef
  5. DNA binding and Topoisomerase inhibition: How can these mechanisms be explored to design more specific anticancer agents?
    Sinara Mônica Vitalino de Almeida et al, 2017, Biomedicine & Pharmacotherapy CrossRef
  6. null
    Jerry W. Snow et al, 2017 CrossRef
  7. Design, synthesis, and biological evaluation of indole carboxylic acid esters of podophyllotoxin as antiproliferative agents
    Lei Zhang et al, 2018, Med Chem Res CrossRef
  8. null
    Jerry W. Snow et al, 2016 CrossRef
  9. Synthesis and biological evaluation of a novel artesunate–podophyllotoxin conjugate as anticancer agent
    Lei Zhang et al, 2016, Bioorganic & Medicinal Chemistry Letters CrossRef
  10. Synthesis and biological evaluation of novel podophyllotoxin-NSAIDs conjugates as multifunctional anti-MDR agents against resistant human hepatocellular carcinoma Bel-7402/5-FU cells
    Lei Zhang et al, 2017, European Journal of Medicinal Chemistry CrossRef
  11. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
    Amit S. Choudhari et al, 2020, Front. Pharmacol. CrossRef
  12. Current scenario of indole derivatives with potential anti-drug-resistant cancer activity
    Yanshu Jia et al, 2020, European Journal of Medicinal Chemistry CrossRef
  13. Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy
    Wei Zhao et al, 2020, Nat. Prod. Rep. CrossRef
  14. Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010-2020)
    Jiaqi Xiao et al, 2020, European Journal of Medicinal Chemistry CrossRef
  15. Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus–Driven Head and Neck Cancer: Current Evidence and Future Prospects
    Nikita Aggarwal et al, 2021, Front. Pharmacol. CrossRef
  16. Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs
    Hua-yang Fan et al, 2021, Front. Cell Dev. Biol. CrossRef
  17. A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship
    Kishor Mazumder et al, 2022, Molecules CrossRef
  18. Natural product inspired leads in the discovery of anticancer agents: an update
    Firdoos Ahmad Sofi et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
  19. Phytochemicals as Chemo-Preventive Agents and Signaling Molecule Modulators: Current Role in Cancer Therapeutics and Inflammation
    Muhammad Bilal Ahmed et al, 2022, IJMS CrossRef
  20. null
    Mehak Sharan et al, 2023 CrossRef
  21. null
    Sachin Puri et al, 2023 CrossRef
  22. null
    Marwa A.A. Fayed et al, 2023 CrossRef
  23. PeruNPDB: the Peruvian Natural Products Database for in silico drug screening
    Haruna L. Barazorda-Ccahuana et al, 2023, Sci Rep CrossRef
  24. Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review
    Bapi Gorain et al, 2023, International Journal of Biological Macromolecules CrossRef
  25. Research status of indole-modified natural products
    Song-Fang Duan et al, 2023, RSC Med. Chem. CrossRef
  26. null
    Bhavana Jodha et al, 2024 CrossRef
  27. Synergistic Cytotoxicity of Extracts of Chaga Mushroom and Microalgae against Mammalian Cancer Cells In Vitro
    Sajeev Wagle et al, 2024, Oxidative Medicine and Cellular Longevity CrossRef
  28. Solid Lipid Nanoparticles for the Delivery of Plant-derived Bioactive Compounds in the Treatment of Cancer Disorders – A Review
    Kumara Swamy Samanthula et al, 2024, JNR CrossRef
  29. First dual inhibitors of human topoisomerase IIα and Hsp90 C-terminal domain inhibit the growth of Ewing sarcoma in vitro and in vivo
    Jaka Dernovšek et al, 2024, Bioorganic Chemistry CrossRef